These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32506817)

  • 1. Specific donor HLA allotypes as predictors of cytomegalovirus disease risk in acute myeloid leukemia.
    Min GJ; Kim HJ; Kim TG; Hyun YS; Hyun SJ; Baek IC; Yoon SY; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW
    HLA; 2020 Oct; 96(4):445-455. PubMed ID: 32506817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haploidentical allogeneic hematopoietic stem cell transplantation increases the risk of cytomegalovirus infection in adult patients with acute leukemia.
    Lin CH; Su YJ; Hsu CY; Wang PN; Teng CJ
    Transpl Infect Dis; 2019 Aug; 21(4):e13096. PubMed ID: 31004545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation.
    Du J; Liu J; Gu J; Zhu P
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1417-21. PubMed ID: 18022570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy.
    Behrendt CE; Rosenthal J; Bolotin E; Nakamura R; Zaia J; Forman SJ
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):54-60. PubMed ID: 19135943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT.
    Schmidt-Hieber M; Tridello G; Ljungman P; Mikulska M; Knelange N; Blaise D; Socié G; Volin L; Blijlevens N; Fegueux N; Yakoub-Agha I; Forcade E; Maertens J; Chevallier P; Passweg J; Cornelissen J; Russell N; Craddock C; Bourhis JH; Marchand T; Reményi P; Cahn JY; Michallet M; Montoto S; Kröger N; Glaß B; Styczynski J
    Ann Hematol; 2019 Jul; 98(7):1755-1763. PubMed ID: 30993417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between HLA tissue type, CMV infection, and acute graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: single-center experience.
    Kekik C; Besisik SK; Seyhun Y; Oguz FS; Sargin D; Carin MN
    Transplant Proc; 2009 Nov; 41(9):3859-62. PubMed ID: 19917401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation.
    Prem S; Remberger M; Alotaibi A; Lam W; Law AD; Kim DDH; Michelis FV; Al-Shaibani Z; Lipton JH; Mattsson J; Viswabandya A; Kumar R; Ellison C
    Transpl Infect Dis; 2022 Aug; 24(4):e13879. PubMed ID: 35706108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
    Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
    Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical Analysis of Cytomegalovirus Infection after Different Patterns of Hematopoietic Stem Cell Transplantation].
    Wang S; Liu DB; Zheng XL; Ding L; Han DM; Wang ZD; Yan HM; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1438-44. PubMed ID: 26524053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of real time polymerase chain reaction to the diagnosis and treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation].
    Chen H; Liu KY; Xu LP; Liu DH; Chen YH; Zhao XS; Yu L; Han W; Zhang XH; Wang Y; Chen Y; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):77-81. PubMed ID: 19563015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison.
    Devillier R; Legrand F; Rey J; Castagna L; Fürst S; Granata A; Charbonnier A; Harbi S; d'Incan E; Pagliardini T; Faucher C; Lemarie C; Saillard C; Calmels B; Mohty B; Maisano V; Weiller PJ; Chabannon C; Vey N; Blaise D
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1449-1454. PubMed ID: 29448057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The impact of HLA high resolution typing mismatching of donor-recipient pairs on outcome of unrelated donor hematopoietic stem cell transplantation].
    He J; Xu C; Wu XJ; Bao XJ; Qiu QC; Yuan XN; Li Y; Shen HJ; Wu DP; Hong JL; Liu JH; DU HY; Zhang L; DU D; Lu J; Liu J
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):353-7. PubMed ID: 22781790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.
    Ghobadi A; Milton DR; Gowda L; Rondon G; Chemaly RF; Hamdi A; Alousi A; Afrough A; Oran B; Ciurea S; Kebriaei P; Popat UR; Qazilbash MH; Shpall EJ; Champlin RE; Bashir Q
    Curr Res Transl Med; 2019 May; 67(2):51-55. PubMed ID: 30683577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploidentical
    Brissot E; Labopin M; Ehninger G; Stelljes M; Brecht A; Ganser A; Tischer J; Kröger N; Afanasyev B; Finke J; Elmaagacli A; Einsele H; Mohty M; Nagler A
    Haematologica; 2019 Mar; 104(3):524-532. PubMed ID: 30361416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
    Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
    Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of High-Frequency HLA Haplotypes on Clinical Cytomegalovirus Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation.
    Kawase T; Tanaka H; Kojima H; Uchida N; Ohashi K; Fukuda T; Ozawa Y; Ikegame K; Eto T; Mori T; Miyamoto T; Hidaka M; Shiratori S; Takanashi M; Atsuta Y; Ichinohe T; Kanda Y; Kanda J;
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2482-2489. PubMed ID: 31400501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation.
    Ljungman P; Brand R; Hoek J; de la Camara R; Cordonnier C; Einsele H; Styczynski J; Ward KN; Cesaro S;
    Clin Infect Dis; 2014 Aug; 59(4):473-81. PubMed ID: 24850801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of donor cytomegalovirus serological status on the outcome of allogeneic stem cell transplantation].
    Liu J; Fu Q; Wang Y; Wang FR; Han W; Ma YR; Yan CH; Han TT; Wang JZ; Wang ZD; Zhang XH; Xu LP; Liu KY; Huang XJ; Sun YQ
    Zhonghua Nei Ke Za Zhi; 2021 May; 60(5):459-465. PubMed ID: 33906276
    [No Abstract]   [Full Text] [Related]  

  • 20. Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis.
    Ljungman P; Brand R; Einsele H; Frassoni F; Niederwieser D; Cordonnier C
    Blood; 2003 Dec; 102(13):4255-60. PubMed ID: 12933590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.